WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ:TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the following conferences and times:
- Jefferies 2013 Global Healthcare Conference at The Waldorf Hilton, London, England on Thursday, November 21, 2013 at 12:20 p.m. Greenwich Mean Time/7:20 a.m. Eastern Time.
- Deutsche Bank BioFEST at the Four Seasons Hotel, Boston, Massachusetts, on Tuesday, December 3, 2013 at 4:00 p.m. Eastern Time.
The presentations will be webcast and accessible from the Investor Relations page of Targacept’s website, www.targacept.com. To ensure a timely connection to the webcasts, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of each webcast will be available for replay via the Investor Calendar section of the Investor Relations page of Targacept’s website for at least two weeks following the event.
Targacept is developing an advanced clinical pipeline of NNR Therapeutics™ to treat patients suffering from serious nervous system and gastrointestinal/genitourinary diseases and disorders. Many diseases arise from abnormalities in signaling within and between the brain and other organ systems such as the bladder and the GI tract. Targacept’s NNR Therapeutics have the potential to normalize these signaling pathways to provide significant medical benefit. Targacept is dedicated to building health and restoring independence for patients. For more information, please visit www.targacept.com.
Building Health, Restoring Independence®